-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Finch Therapeutics Group, Inc. quarterly and annual General and Administrative Expense in USD history and change rate from 31 Mar 2020 to 30 Jun 2024.
- Finch Therapeutics Group, Inc. General and Administrative Expense for the quarter ending 30 Jun 2024 was $6,109,000, a 31% decline year-over-year.
- Finch Therapeutics Group, Inc. General and Administrative Expense for the twelve months ending 30 Jun 2024 was $19,689,000, a 47% decline year-over-year.
- Finch Therapeutics Group, Inc. annual General and Administrative Expense for 2023 was $26,910,000, a 26% decline from 2022.
- Finch Therapeutics Group, Inc. annual General and Administrative Expense for 2022 was $36,192,000, a 70% increase from 2021.
- Finch Therapeutics Group, Inc. annual General and Administrative Expense for 2021 was $21,238,000, a 52% increase from 2020.